Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 296

1.

Towards a personalized treatment for IgA nephropathy considering pathology and pathogenesis.

Coppo R.

Nephrol Dial Transplant. 2018 Nov 26. doi: 10.1093/ndt/gfy338. [Epub ahead of print]

PMID:
30476257
2.

Is there long-term value of pathology scoring in immunoglobulin A nephropathy? A validation study of the Oxford Classification for IgA Nephropathy (VALIGA) update.

Coppo R, D'Arrigo G, Tripepi G, Russo ML, Roberts ISD, Bellur S, Cattran D, Cook TH, Feehally J, Tesar V, Maixnerova D, Peruzzi L, Amore A, Lundberg S, Di Palma AM, Gesualdo L, Emma F, Rollino C, Praga M, Biancone L, Pani A, Feriozzi S, Polci R, Barratt J, Del Vecchio L, Locatelli F, Pierucci A, Caliskan Y, Perkowska-Ptasinska A, Durlik M, Moggia E, Ballarin JC, Wetzels JFM, Goumenos D, Papasotiriou M, Galesic K, Toric L, Papagianni A, Stangou M, Benozzi L, Cusinato S, Berg U, Topaloglu R, Maggio M, Ots-Rosenberg M, D'Amico M, Geddes C, Balafa O, Quaglia M, Cravero R, Lino Cirami C, Fellstrom B, Floege J, Egido J, Mallamaci F, Zoccali C.

Nephrol Dial Transplant. 2018 Nov 9. doi: 10.1093/ndt/gfy302. [Epub ahead of print]

PMID:
30418652
3.

The Gut-Renal Connection in IgA Nephropathy.

Coppo R.

Semin Nephrol. 2018 Sep;38(5):504-512. doi: 10.1016/j.semnephrol.2018.05.020. Review.

PMID:
30177022
4.

IgA Nephropathy: A European Perspective in the Corticosteroid Treatment.

Coppo R.

Kidney Dis (Basel). 2018 Jun;4(2):58-64. doi: 10.1159/000487265. Epub 2018 Mar 16. Review.

5.

Defective gene expression of the membrane complement inhibitor CD46 in patients with progressive immunoglobulin A nephropathy.

Coppo R, Peruzzi L, Loiacono E, Bergallo M, Krutova A, Russo ML, Cocchi E, Amore A, Lundberg S, Maixnerova D, Tesar V, Perkowska-Ptasinska A, Durlik M, Goumenos D, Gerolymos M, Galesic K, Toric L, Papagianni A, Stangou M, Mizerska-Wasia Membek M, Gesualdo L, Montemurno E, Benozzi L, Cusinato S, Hryszko T, Klinger M, Kaminska D, Krajewska M; VALIGA Study Group of the ERA-EDTA Immunonephrology Working Group.

Nephrol Dial Transplant. 2018 Apr 9. doi: 10.1093/ndt/gfy064. [Epub ahead of print]

PMID:
29635535
6.

Treatment of IgA nephropathy: Recent advances and prospects.

Coppo R.

Nephrol Ther. 2018 Apr;14 Suppl 1:S13-S21. doi: 10.1016/j.nephro.2018.02.010. Review.

PMID:
29606258
7.

Standardization of pediatric uroradiological terms: A multidisciplinary European glossary.

Vivier PH, Augdal TA, Avni FE, Bacchetta J, Beetz R, Bjerre AK, Blickman J, Cochat P, Coppo R, Damasio B, Darge K, El-Ghoneimi A, Hoebeke P, Läckgren G, Leclair MD, Lobo ML, Manzoni G, Marks SD, Mattioli G, Mentzel HJ, Mouriquand P, Nevéus T, Ntoulia A, Ording-Muller LS, Oswald J, Papadopoulou F, Porcellini G, Ring E, Rösch W, Teixeira AF, Riccabona M.

J Pediatr Urol. 2017 Dec;13(6):641-650. doi: 10.1016/j.jpurol.2017.05.026. Epub 2017 Jul 13.

PMID:
29174378
8.

Standardization of pediatric uroradiological terms: a multidisciplinary European glossary.

Vivier PH, Augdal TA, Avni FE, Bacchetta J, Beetz R, Bjerre AK, Blickman J, Cochat P, Coppo R, Damasio B, Darge K, El-Ghoneimi A, Hoebeke P, Läckgren G, Leclair MD, Lobo ML, Manzoni G, Marks SD, Mattioli G, Mentzel HJ, Mouriquand P, Nevéus T, Ntoulia A, Ording-Muller LS, Oswald J, Papadopoulou F, Porcellini G, Ring E, Rösch W, Teixeira AF, Riccabona M.

Pediatr Radiol. 2018 Feb;48(2):291-303. doi: 10.1007/s00247-017-4006-7. Epub 2017 Nov 15. Review.

9.

Glomerular disease frequencies by race, sex and region: results from the International Kidney Biopsy Survey.

O'Shaughnessy MM, Hogan SL, Thompson BD, Coppo R, Fogo AB, Jennette JC.

Nephrol Dial Transplant. 2017 Jul 2. doi: 10.1093/ndt/gfx189. [Epub ahead of print]

PMID:
29106637
10.

Differential diagnosis of thrombotic microangiopathy in nephrology.

Sakari Jokiranta T, Viklicky O, Al Shorafa S, Coppo R, Gasteyger C, Macia M, Pankratenko T, Shenoy M, Soylemezoglu O, Tsimaratos M, Wetzels J, Haller H.

BMC Nephrol. 2017 Oct 28;18(1):324. doi: 10.1186/s12882-017-0727-y.

11.

Persistent Microscopic Hematuria as a Risk Factor for Progression of IgA Nephropathy: New Floodlight on a Nearly Forgotten Biomarker.

Coppo R, Fervenza FC.

J Am Soc Nephrol. 2017 Oct;28(10):2831-2834. doi: 10.1681/ASN.2017060639. Epub 2017 Jul 24. No abstract available.

12.

HERV-K and W expression in peripheral mononuclear cells of children with Henoch-Schönlein purpura and relation with TLRs activation.

Bergallo M, Loiacono E, Galliano I, Montanari P, Peruzzi L, Tovo PA, Coppo R.

Minerva Pediatr. 2017 May 4. doi: 10.23736/S0026-4946.17.04717-X. [Epub ahead of print]

PMID:
28472872
13.

The gut-kidney axis in IgA nephropathy: role of microbiota and diet on genetic predisposition.

Coppo R.

Pediatr Nephrol. 2018 Jan;33(1):53-61. doi: 10.1007/s00467-017-3652-1. Epub 2017 Apr 7.

PMID:
28389744
14.

Targeted-release budesonide versus placebo in patients with IgA nephropathy (NEFIGAN): a double-blind, randomised, placebo-controlled phase 2b trial.

Fellström BC, Barratt J, Cook H, Coppo R, Feehally J, de Fijter JW, Floege J, Hetzel G, Jardine AG, Locatelli F, Maes BD, Mercer A, Ortiz F, Praga M, Sørensen SS, Tesar V, Del Vecchio L; NEFIGAN Trial Investigators.

Lancet. 2017 May 27;389(10084):2117-2127. doi: 10.1016/S0140-6736(17)30550-0. Epub 2017 Mar 28.

PMID:
28363480
15.

Oxford Classification of IgA nephropathy 2016: an update from the IgA Nephropathy Classification Working Group.

Trimarchi H, Barratt J, Cattran DC, Cook HT, Coppo R, Haas M, Liu ZH, Roberts IS, Yuzawa Y, Zhang H, Feehally J; IgAN Classification Working Group of the International IgA Nephropathy Network and the Renal Pathology Society; Conference Participants.

Kidney Int. 2017 May;91(5):1014-1021. doi: 10.1016/j.kint.2017.02.003. Epub 2017 Mar 22. Review.

16.

C4d deposits in IgA nephropathy: where does complement activation come from?

Coppo R.

Pediatr Nephrol. 2017 Jul;32(7):1097-1101. doi: 10.1007/s00467-016-3575-2. Epub 2017 Feb 14. No abstract available.

PMID:
28197885
17.

Clinical and histological risk factors for progression of IgA nephropathy: an update in children, young and adult patients.

Coppo R.

J Nephrol. 2017 Jun;30(3):339-346. doi: 10.1007/s40620-016-0360-z. Epub 2016 Nov 4. Review.

PMID:
27815919
18.

Erratum to: Risk factors for progression in children and young adults with IgA nephropathy: an analysis of 261 cases from the VALIGA European cohort.

Coppo R, Lofaro D, Camilla RR, Bellur S, Cattran D, Cook HT, Roberts IS, Peruzzi L, Amore A, Emma F, Fuiano L, Berg U, Topaloglu R, Bilginer Y, Gesualdo L, Polci R, Mizerska-Wasiak M, Caliskan Y, Lundberg S, Cancarini G, Geddes C, Wetzels J, Wiecek A, Durlik M, Cusinato S, Rollino C, Maggio M, Praga M, Smerud HK, Tesar V, Maixnerova D, Barratt J, Papalia T, Bonofiglio R, Mazzucco G, Giannakakis C, Soderberg M, Orhan D, Di Palma AM, Maldyk J, Ozluk Y, Sudelin B, Tardanico R, Kipgen D, Steenbergen E, Karkoszka H, Perkowska-Ptasinska A, Ferrario F, Gutierrez E, Honsova E.

Pediatr Nephrol. 2017 Jan;32(1):193-194. No abstract available.

19.

Corticosteroids in IgA Nephropathy: Lessons from Recent Studies.

Coppo R.

J Am Soc Nephrol. 2017 Jan;28(1):25-33. doi: 10.1681/ASN.2016060647. Epub 2016 Sep 26. Review.

20.

A Multicenter Study of the Predictive Value of Crescents in IgA Nephropathy.

Haas M, Verhave JC, Liu ZH, Alpers CE, Barratt J, Becker JU, Cattran D, Cook HT, Coppo R, Feehally J, Pani A, Perkowska-Ptasinska A, Roberts IS, Soares MF, Trimarchi H, Wang S, Yuzawa Y, Zhang H, Troyanov S, Katafuchi R.

J Am Soc Nephrol. 2017 Feb;28(2):691-701. doi: 10.1681/ASN.2016040433. Epub 2016 Sep 9. Erratum in: J Am Soc Nephrol. 2017 May;28(5):1665.

Supplemental Content

Loading ...
Support Center